Endothelin-1 gene polymorphism (G8002A) and endothelial monocyte-activating polypeptide II: Role in vascular dysfunction in pediatric patients with β-thalassemia …

AAG Tantawy, MAR Tadros, AAM Adly, EAR Ismail… - Cytokine, 2023 - Elsevier
Abstract Background: Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates
production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II …

Endothelin-1 gene polymorphism (G8002A) and endothelial monocyte-activating polypeptide II: Role in vascular dysfunction in pediatric patients with β-thalassemia …

AAG Tantawy, MAR Tadros, AAM Adly… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates
production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II …

Endothelin-1 gene polymorphism (G8002A) and endothelial monocyte-activating polypeptide II: Role in vascular dysfunction in pediatric patients with β-thalassemia …

AAG Tantawy, MAR Tadros, AAM Adly, EAR Ismail… - Cytokine, 2022 - europepmc.org
Background Endothelin-1 (ET-1), a potent endogenous vasoconstrictor, stimulates
production of reactive oxygen species. Endothelial monocyte-activating polypeptide-II …